Company / Operating Cash Flow per Share
Pacira BioSciences, Inc. Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$3.29
FY2025
5-year range
$1.62 / $4.10
FY2021-FY2025
Trend
-19.7%
vs FY2024
Sector context
#30 of 212
Health Care
What the data says
Pacira BioSciences, Inc.'s operating cash flow per share of $3.29 is higher than 86% of companies in the Health Care sector (FY2025). Operating Cash Flow per Share has fluctuated over the past 10 years, ranging from $0.43 in FY2019 to $4.10 in FY2024.
Based on SEC 10-K filings.
3.29 in FY2025 with a 5-year CAGR of +23.0%. Top quartile in the Health Care sector.
Declined from $3.37 to $3.29 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- +0.4%
- 5-Year CAGR
- +23.0%
- 10-Year CAGR
- -
Sector benchmark
-37.7% below sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share decreased 19.7% year-over-year.
- Ranks #30 out of 212 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2024.
- Lowest operating cash flow per share in the period was in FY2019.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Negative profit margin: -14.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.29 | -19.7% |
| FY2024 | $4.10 | +21.6% |
| FY2023 | $3.37 | +3.7% |
| FY2022 | $3.25 | +101.0% |
| FY2021 | $1.62 | +38.6% |
| FY2020 | $1.17 | +170.3% |
| FY2019 | $0.43 | -47.6% |
| FY2018 | $0.82 | +10.0% |
| FY2017 | $0.75 | -17.7% |
| FY2016 | $0.91 | +17.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026